NasdaqGS - Nasdaq Real Time Price USD

Alphatec Holdings, Inc. (ATEC)

12.44

+0.20

(+1.63%)

At close: April 26 at 4:00 PM EDT

12.48

+0.04

(+0.32%)

After hours: April 26 at 7:47 PM EDT

ATEC to Report First Quarter Financial Results on May 7, 2024

CARLSBAD, Calif., April 17, 2024--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report first quarter 2024 financial results on May 7, 2024, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET.

Business Wire 11 days ago
ATEC Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Corporate Highlights

CARLSBAD, Calif., February 27, 2024--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter and full year ended December 31, 2023, and business highlights.

Business Wire last month
ATEC to Present at Upcoming Conferences

CARLSBAD, Calif., January 29, 2024--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that management will participate in the following investor conferences:

Business Wire 2 months ago
ATEC Announces Record Preliminary Revenue Results for 2023 and 2024 Revenue Guidance

CARLSBAD, Calif., January 08, 2024--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today preliminary revenue results for the fourth quarter and full-year ended December 31, 2023, and provided revenue guidance for full-year 2024.

Business Wire 3 months ago
Aclarion and ATEC Execute Strategic Partnership Agreement to Advance Commercialization of Nociscan

Partnership aims to include Aclarion’s surgical decision support technology within ATEC’s AlphaInformatiX platform to better inform spine surgery Aclarion’s Nociscan is the first augmented intelligence platform to measure pain biomarkers in the lumbar spine to help physicians identify the location of chronic low back pain BROOMFIELD, CO, Jan. 08, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that

GlobeNewswire 3 months ago
ATEC to Present at the 2024 J.P. Morgan Healthcare Conference

CARLSBAD, Calif., December 19, 2023--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that management will present at the J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco, CA, at 3:45pm PT on January 10, 2024.

Business Wire 4 months ago
ATEC Reports Third Quarter 2023 Financial Results and Raises Full Year 2023 Adjusted EBITDA Guidance

CARLSBAD, Calif., November 06, 2023--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended September 30, 2023, and recent corporate highlights.

Business Wire 5 months ago
ATEC to Participate in Upcoming Investor Conferences

CARLSBAD, Calif., November 01, 2023--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that management will participate in the following investor events:

Business Wire 5 months ago
ATEC Equipped to Support Ramping Surgical Volume With Proceeds From Secondary Offering

CARLSBAD, Calif., October 31, 2023--Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that the successful close of a $150 million secondary offering on October 27, 2023, positions the Company to accelerate investment in the revenue-generating assets required to capitalize on industry disruption.

Business Wire 5 months ago
ATEC Announces Closing of Public Stock Offering

CARLSBAD, Calif., October 27, 2023--Alphatec Holdings, Inc. ("ATEC") (NASDAQ: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced the closing of its previously announced underwritten public offering of 14,300,000 shares of its common stock at a public offering price of $10.50 per share.

Business Wire 5 months ago
ATEC Announces Pricing of Public Offering of Common Stock

CARLSBAD, Calif., October 25, 2023--Alphatec Holdings, Inc. ("ATEC") (NASDAQ: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced the pricing of an underwritten public offering of 14,300,000 shares of its common stock at a public offering price of $10.50 per share. The offering is expected to close on October 27, 2023, subject to the satisfaction of customary closing conditions. In connection with the offering, ATEC has granted th

Business Wire 6 months ago
ATEC Announces Proposed Public Offering of Common Stock

CARLSBAD, Calif., October 24, 2023--Alphatec Holdings, Inc. ("ATEC") (NASDAQ: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced that it has commenced a proposed underwritten public offering of $150 million of shares of its common stock. In connection with the proposed offering, ATEC intends to grant the underwriters a 30-day option to purchase up to an additional $22.5 million of shares of its common stock sold in the offering.

Business Wire 6 months ago
Aclarion Announces Signing Strategic Partnership Letter of Intent With ATEC to Advance Commercialization of Nociscan

Partnership aims to include Aclarion’s Nociscan surgical decisioning technology within ATEC’s AlphaInformatiX platform to better inform spine surgery ATEC is a medical device company dedicated to revolutionizing the approach to spine surgery through clinical distinction Aclarion’s Nociscan is the first augmented intelligence platform to measure disc health biomarkers in the lumbar spine to help physicians identify the location of chronic low back pain BROOMFIELD, CO, Oct. 23, 2023 (GLOBE NEWSWIR

GlobeNewswire 6 months ago
ATEC Enhances Board with Renowned Spine Prowess

CARLSBAD, Calif., October 17, 2023--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that Dave Demski, former director and Chief Executive Officer of Globus Medical, has been appointed as an independent director to the Board. The Company also announced that Keith Valentine, former Chief Executive Officer of Orthofix, has been appointed Special Advisor to the Board.

Business Wire 6 months ago
ATEC to Preview the Informatics Sophistication of EOS Catalyst™ at NASS 2023

CARLSBAD, Calif., October 17, 2023--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that EOS Catalyst will be introduced at the 2023 NASS Annual Meeting. EOS Catalyst builds on the already unprecedented functionality of the EOS imaging platform with automated alignment and surgical planning capabilities.

Business Wire 6 months ago
ATEC Advances Lateral Surgery With Launch of Expandable Technology

CARLSBAD, Calif., October 16, 2023--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that the Company’s commitment to advancing lateral surgery will be prominent at the 2023 NASS Annual Meeting. The Company will introduce the Calibrate LTXTM lateral expandable implant system, technology designed to better achieve alignment goals with precise lordosis control and disc height restoration.

Business Wire 6 months ago
ATEC Announces Preliminary Third Quarter 2023 Revenue Results and Raises Full-Year Revenue Guidance

CARLSBAD, Calif., October 16, 2023--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today select preliminary financial results for the third quarter ended September 30, 2023, and updated full-year 2023 revenue guidance ahead of investor meetings scheduled during the 2023 North American Spine Society (NASS) Annual Meeting.

Business Wire 6 months ago
ATEC Clinical Precision and Predictability on Display at NASS 2023

CARLSBAD, Calif., October 09, 2023--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that the Company will feature technology designed to advance its comprehensive procedural solutions at the North American Spine Society (NASS) 38th Annual Meeting, which will be held at the Los Angeles Convention Center in California from October 18 to 21, 2023.

Business Wire 6 months ago
ATEC Reports Second Quarter 2023 Financial Results and Raises Full Year 2023 Revenue and Adjusted EBITDA Guidance

CARLSBAD, Calif., August 03, 2023--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended June 30, 2023, and recent corporate highlights.

Business Wire 8 months ago
ATEC to Report Second Quarter Financial Results on August 3, 2023

CARLSBAD, Calif., July 18, 2023--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report second quarter 2023 financial results on August 3, 2023, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET.

Business Wire 9 months ago

Performance Overview

Return	ATEC	S&P 500
YTD	-17.67%	+6.92%
1-Year	-16.79%	+25.26%
3-Year	-25.55%	+22.00%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Alphatec Holdings, Inc. (ATEC)

ATEC to Report First Quarter Financial Results on May 7, 2024

ATEC Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Corporate Highlights

ATEC to Present at Upcoming Conferences

ATEC Announces Record Preliminary Revenue Results for 2023 and 2024 Revenue Guidance

Aclarion and ATEC Execute Strategic Partnership Agreement to Advance Commercialization of Nociscan

ATEC to Present at the 2024 J.P. Morgan Healthcare Conference

ATEC Reports Third Quarter 2023 Financial Results and Raises Full Year 2023 Adjusted EBITDA Guidance

ATEC to Participate in Upcoming Investor Conferences

ATEC Equipped to Support Ramping Surgical Volume With Proceeds From Secondary Offering

ATEC Announces Closing of Public Stock Offering

ATEC Announces Pricing of Public Offering of Common Stock

ATEC Announces Proposed Public Offering of Common Stock

Aclarion Announces Signing Strategic Partnership Letter of Intent With ATEC to Advance Commercialization of Nociscan

ATEC Enhances Board with Renowned Spine Prowess

ATEC to Preview the Informatics Sophistication of EOS Catalyst™ at NASS 2023

ATEC Advances Lateral Surgery With Launch of Expandable Technology

ATEC Announces Preliminary Third Quarter 2023 Revenue Results and Raises Full-Year Revenue Guidance

ATEC Clinical Precision and Predictability on Display at NASS 2023

ATEC Reports Second Quarter 2023 Financial Results and Raises Full Year 2023 Revenue and Adjusted EBITDA Guidance

ATEC to Report Second Quarter Financial Results on August 3, 2023

Performance Overview